Ameritas Investment Partners, Inc. Cytom X Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.53 - $2.89 $7,665 - $14,478	-5,010 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.6 - $9.0 $8,718 - $11,889	1,321 Added 35.81%	5,010 $39,000
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $4,275 - $8,622	450 Added 13.89%	3,689 $40,000
Q2 2018 Aug 13, 2018	BUY	$21.38 - $29.68 $14,730 - $20,449	689 Added 27.02%	3,239 $74,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,550	2,550 $40,000

46.1M

3.7K

4.7K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $52.1M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.